KRAS and neoplasm: We depicted the first KRAS mutation landscape of rare tumors in a large Chinese rare tumor population and observed an overall prevalence of 8.7% of KRAS mutation, concentrated on G12D, G12V, and G13D (Wang et al, 2022a).